News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Vadim Koshkin: Our recent work highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab
Photo from Vadim Koshkin/X
Jun 1, 2024, 23:26

Vadim Koshkin: Our recent work highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab

Vadim Koshkin, Assistant Professor at University of California, San Francisco, shared a post on X/Twitter:

”Our recent work in European Urology Focus with Jason Brown, Case Comp Cancer Center highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab.

Therapies After Progression on Enfortumab Vedotin and Pembrolizumab: Navigating Second-line Options for Metastatic Urothelial Carcinoma in the New Treatment Landscape.”

Source: Vadim Koshkin/X

cancer Case Comp Cancer Center Enfortumab vedotin European Urology Focus Jason Brown metastatic urothelial carcinoma OncoDaily Oncology pembrolizumab University of California Vadim Koshkin
Special Coverage
Societies
Apr 26, 2025, 08:02
10 Caring Notes from Pope Francis on Healthcare
Blog
Apr 26, 2025, 05:35
St. Baldrick's Foundation - Celebrating Our Volunteer Barbers: Bringing Hope, One Haircut at a Time
Blog
Apr 26, 2025, 05:30
Duke Radiation Oncology - Erik Sulman Named Chair of Radiation Oncology at Duke University School of Medicine
Blog
Apr 26, 2025, 05:17
Bernard A. Fox: Heading to AACR2025 to talk about our work on cancer immunotherapy for HNSCC
Blog
Apr 26, 2025, 05:03
Katsuaki Maehara: CXCL13-Reprogrammed Macrophages Drive Cancer-Associated Pulmonary Embolism
Blog
Apr 26, 2025, 04:56
Peter Pisters: MD Anderson Cancer Center Experts Lead the Way at AACR2025
Opinion
Apr 26, 2025, 03:09
Annual Report to the Nation on the Status of Cancer - NCI Division of Cancer Control and Population Sciences
Insight
Apr 26, 2025, 00:43
Navneet Majhail: Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring
Blog
Apr 26, 2025, 00:17
Amol Akhade: Excited for the positive news on PFS for Destiny 09
Blog
Apr 25, 2025, 23:48
Gevorg Tamamyan shares inspiring meeting with Princess Adila bint Abdullah Al Saud at SIOP Asia 2025
Blog
Apr 25, 2025, 23:37
Binay Shah: Walk Along Seattle Waterfront Ahead of SCHD25
Blog
Apr 25, 2025, 20:27
Daniel Chen and Synthetic Design Lab announce $20M launch to advance ADC innovation